Filing Details
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:LXEO
Lexeo Therapeutics, Inc. (LXEO) Files Quarterly Report for Q0
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
At publication ·
What changed
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Lexeo Therapeutics filed its quarterly report (Form 10-Q) with the SEC on August 12, 2026.
- The company's stock trades at $4.87 per share with a market capitalization of $715.6 million.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
Lexeo Therapeutics, Inc.'s stock currently trades at $4.87 with a market capitalization of $715.6M.
The 10-Q provides Lexeo Therapeutics, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Lexeo Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View LXEO Stock Page
Frequently Asked Questions
Where can I read LXEO's SEC filings?
Browse all filings on our LXEO SEC filings page.
What types of SEC filings does Lexeo Therapeutics, Inc. file?
Public companies like Lexeo Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.